| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Wellcome Trust Case Control Consortium Nature 447 (7145), 661, 2007 | 7802 | 2007 |
| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378 (6559), 789-792, 1995 | 4182 | 1995 |
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 3913 | 2003 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3522 | 1998 |
| Patterns of somatic mutation in human cancer genomes C Greenman, P Stephens, R Smith, GL Dalgliesh, C Hunter, G Bignell, ... Nature 446 (7132), 153-158, 2007 | 3165 | 2007 |
| Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL J Zha, H Harada, E Yang, J Jockel, SJ Korsmeyer Cell 87 (4), 619-628, 1996 | 3058 | 1996 |
| Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2548 | 2007 |
| Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ... Science 265 (5181), 2088-2090, 1994 | 2384 | 1994 |
| Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease B Ravikumar, C Vacher, Z Berger, JE Davies, S Luo, LG Oroz, F Scaravilli, ... Nature genetics 36 (6), 585-595, 2004 | 2377 | 2004 |
| Risks of cancer in BRCA1-mutation carriers D Ford, DF Easton, DT Bishop, SA Narod, DE Goldgar The Lancet 343 (8899), 692-695, 1994 | 2211 | 1994 |
| Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. DF Easton, D Ford, DT Bishop American journal of human genetics 56 (1), 265, 1995 | 1976 | 1995 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 1852 | 1998 |
| International network of cancer genome projects International Cancer Genome Consortium Nature 464 (7291), 993, 2010 | 1711 | 2010 |
| Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. DF Easton, DT Bishop, D Ford, GP Crockford American journal of human genetics 52 (4), 678, 1993 | 1702* | 1993 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1567 | 2012 |
| Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. PR Burton, DG Clayton, LR Cardon, N Craddock, P Deloukas, ... Nature genetics 39 (11), 1329-1337, 2007 | 1227 | 2007 |
| Cancer incidence in BRCA1 mutation carriers D Thompson, DF Easton Journal of the National Cancer Institute 94 (18), 1358-1365, 2002 | 1207 | 2002 |
| Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations CHEK2-Breast Cancer Consortium Nature genetics 31 (1), 55, 2002 | 1205 | 2002 |
| Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) MARIBS Study Group The Lancet 365 (9473), 1769-1778, 2005 | 1177 | 2005 |
| Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands DE Goldgar, DF Easton, LA Cannon-Albright, MH Skolnick JNCI: Journal of the National Cancer Institute 86 (21), 1600-1608, 1994 | 1147 | 1994 |
Paul PharoahUniversity of CambridgeVerified email at medschl.cam.ac.uk
